3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Sarcoma
23
Lymphoma
16
Osteosarcoma
11
Lymphoma, Large B-Cell, Diffuse
11
Hodgkin Disease
11
Testicular Neoplasms
10
Lymphoma, Non-Hodgkin
10
Teratoma
8
Ovarian Neoplasms
7
Testicular Germ Cell Tumor
6
Neuroectodermal Tumors, Primitive, Peripheral
6
Neoplasms
6
Burkitt Lymphoma
6
Recurrence
5
Endodermal Sinus Tumor
5
Central Nervous System Neoplasms
5
Carcinoma, Embryonal
5
Lymphoma, Large-Cell, Anaplastic
4
Seminoma
3
Rhabdomyosarcoma
3
Precursor Cell Lymphoblastic Leukemia-Lymphoma
3
Ovarian Germ Cell Cancer
3
Neurofibrosarcoma
3
Lymphoma, Mantle-Cell
3
Lymphoma, B-Cell
3
Histiocytoma, Malignant Fibrous
3
Fibrosarcoma
3
Vomiting
2
Sarcoma, Synovial
2
Sarcoma, Alveolar Soft Part
2
Interventions
Cisplatin
32
human papillomavirus vaccine, L1 type 16, 18
16
Brachytherapy
15
Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18
12
Paclitaxel
11
Bevacizumab
11
pembrolizumab
10
Platinum
9
1,2-diaminocyclohexaneplatinum II citrate
9
Topotecan
8
Radiotherapy, Intensity-Modulated
8
Radiation
8
Papillomavirus Vaccines
8
atezolizumab
6
Gemcitabine
6
Fluorodeoxyglucose F18
6
Cyclophosphamide
6
tisotumab vedotin
5
fludarabine phosphate
5
fludarabine
5
aldesleukin
5
Taxes
5
Radiotherapy
5
Magnetic Resonance Spectroscopy
5
Carboplatin
5
Vaccines, Synthetic
4
Nivolumab
4
Immunoglobulin G
4
Disulfides
4
Colposcopy
4
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Uterine Cervical Neoplasms
×
Ifosfamide
×
Clear all
No trials found.